About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Detroit | 7,240 Studies Near You

Clinical TrialsDetroit

Clinical Trials in Detroit

Discover 7,240 clinical trials near Detroit, Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3061-3080 of 7,240 trials

CompletedCarmustine Implants in Treating Patients With Brain MetastasesRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003878·Birmingham, Alabama and 10 others Active not recruitingPromote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility LossThe PROVE Trial is a randomized clinical trial that will determine whether a weight loss intervention combined with walking exercise achieves greater improvement or less decline…NCT04228978·Chicago, Illinois and 6 others

Find Trials by Condition in Detroit

Breast Cancerin Detroit Lung Cancerin Detroit Prostate Cancerin Detroit Colorectal Cancerin Detroit Melanomain Detroit Leukemiain Detroit Lymphomain Detroit Pancreatic Cancerin Detroit Ovarian Cancerin Detroit Brain Cancerin Detroit Diabetes

Data from ClinicalTrials.govTerms

RecruitingA Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)The purpose of this study is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) of bleximenib in phase 1 Part 1 (Dose Escalation) and to determine the safety and…NCT04811560·Duarte, California and 101 others

CompletedStudy of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)This study is to evaluate the safety and anti-tumor activity of ASP3026 in patients with advanced malignancies (solid tumors and B-cell lymphoma).NCT01284192·Orange, California and 5 others

CompletedOpen-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 TrialThe purpose of the study is to evaluate the safety, tolerability and activity of Fampridine-SR when administered for up to 36 additional months in patients who previously…NCT00649792·Phoenix, Arizona and 41 others

CompletedPhase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-FilgrastimThe study will assess the efficacy of LA-EP2006 compared to Neulasta® with respect to the mean duration of severe neutropenia during treatment with myelosuppressive chemotherapy…NCT01516736·Hot Springs, Arkansas and 52 others

Not yet recruitingAssessing the Effects of Ongoing Ocrelizumab (OCR) Therapy on Fatigue and Cognition in Veterans With Multiple SclerosisThis study seeks to assess the effects of long-term ocrelizumab therapy on fatigue (extreme tiredness) as well as cognition (thinking and reasoning skills, such as memory…NCT07181811·Detroit, Michigan

CompletedVTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal CancerThe purpose of this study is to compare the overall survival of patients treated with VTX-2337 + pegylated liposomal doxorubicin (PLD) versus those treated with PLD alone in women…NCT01666444·Phoenix, Arizona and 135 others

CompletedA Study of HIV Levels During Pregnancy and After ChildbirthThe purpose of this study is to find out if HIV-infected pregnant women taking anti-HIV drugs have an increased amount of HIV in their blood (viral load) after having the baby.NCT00041964·Birmingham, Alabama and 31 others

CompletedZiconotide Effectiveness and Safety Trial in Patients With Chronic Severe PainThe purpose of this open-label study is to give chronic severe pain patients with existing intrathecal pump systems access to ziconotide.NCT00076544·Huntsville, Alabama and 64 others

TerminatedStudy Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple MyelomaSTR (Skeletal Targeted Radiotherapy, 166Ho-DOTMP) is an investigational radiopharmaceutical that delivers radiation directly to cancer cells in the bone and bone marrow.NCT00083564·Birmingham, Alabama and 20 others

CompletedThe BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCCThe BURAN study is a randomized, open-label phase III study to assess the treatment effect of once-daily buparlisib in combination with weekly paclitaxel compared to weekly…NCT04338399·Duarte, California and 161 others

TerminatedAn Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian CancerThe study is being conducted to find out if paclitaxel works better when given together with an experimental drug called MORAb-003 (farletuzumab) or alone in patients with…NCT00738699·Mobile, Alabama and 60 others

CompletedTwo Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006017·Detroit, Michigan and 1 other

CompletedPulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated InfectionThe objective is to conduct a prospective, sham controlled, double-blinded, interventional crossover trial to compare standard terminal cleaning plus PX-UV (intervention) with…NCT03349268·Detroit, Michigan

CompletedDenosumab in Treating Patients With Recurrent or Refractory OsteosarcomaThis phase II trial studies how well denosumab works in treating patients with osteosarcoma that has come back (recurrent) or does not respond to treatment (refractory).NCT02470091·Birmingham, Alabama and 140 others

CompletedFerric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on DialysisThe purpose of this study is to determine if KRX-0502 (ferric citrate) is a safe and effective treatment for the management of serum phosphorus levels and iron deficiency in…NCT01736397·Tempe, Arizona and 19 others

CompletedStudy of PEGPH20 With Initial Dexamethasone Premedication Given Intravenously to Patients With Advanced Solid TumorsThis is an open-label, multicenter, dose-escalation, safety, tolerability, pharmacokinetic and pharmacodynamic study in patients with advanced solid tumors.NCT01170897·Scottsdale, Arizona and 4 others

CompletedLung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersThis phase II trial studies how well durvalumab works in treating patients with stage IV squamous cell lung cancer that has come back after previous treatment.NCT02766335·Birmingham, Alabama and 992 others

RecruitingKO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsThis first-in-human (FIH) dose-escalation and dose-validation/expansion study will assess KO-2806, a farnesyltransferase inhibitor (FTI), as a monotherapy and in combination, in…NCT06026410·Phoenix, Arizona and 37 others

PreviousPage 154 of 362Next

in Detroit

Heart Diseasein Detroit